K-0066

N/A

Report date: 2023/05/22 10:17:41
NME

Base Information

Drug NameK-0066
Drug Alias NameK-0066KPI-286
ClassificationSmall molecules
Mechanisms of ActionReceptor protein-tyrosine kinase inhibitors
TargetsReceptor protein-tyrosine kinase
Therapy Area/IndicationsRetinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKala Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesKala Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRetinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A